BioStock: CombiGene positive to new license agreement for CG01
CombiGene has entered into a new license agreement with Spark Therapeutics regarding intellectual property related to the epilepsy project, CG01. CombiGene’s CEO Peter Ekolind believes that they are now in better position to find a new development partner who can take the epilepsy treatment all the way to patients and the market.– We are looking for a partner who can pick up where Spark left off, and with the agreement in place, we can use the data generated over the past two years in our search, says Peter Ekolind.Read the full article at biostock.se :
Color blocking is a strong style statement: Individual pieces in bright colors are fun—and now this trend is also available as a mechanical watch.GLASHÜTTE, JUNE 19, 2024. Poppy red with emerald green, cobalt blue with sunkissed orange—contrasting colors are always a statement, and one that is both confident and eye-catching. Color blocking is particularly effective when a neutral tone is added from time to time so that the strong colors don't completely outdo each other, but rather shine together with confidence. Great importance is often attached to coordinating accessories such as belts
